Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scientific Reports|February 19, 2021
Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney diseaseRenate M Hoogeveen, Simone L Verweij, Yannick Kaiser, et al.
European Heart Journal|October 26, 2017
Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseasesRenate M Hoogeveen, Matthias Nahrendorf, Niels P Riksen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 6, 2019
Netrin-1 and the Grade of Atherosclerosis Are Inversely Correlated in HumansCaroline S Bruikman, Dianne Vreeken, Renate M Hoogeveen, et al.
Atherosclerosis|February 3, 2022
Reduced baroreflex sensitivity and increased splenic activity in patients with severe obstructive sleep apneaYannick Kaiser, Kim E Dzobo, Madeline J L Ravesloot, et al.
European Heart Journal|March 23, 2017
PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemiaSophie J Bernelot Moens, Annette E Neele, Jeffrey Kroon, et al.
European Heart Journal|August 19, 2020
Improved cardiovascular risk prediction using targeted plasma proteomics in primary preventionRenate M Hoogeveen, João P Belo Pereira, Nick S Nurmohamed, et al.
European Heart Journal|February 9, 2022
Targeted proteomics improves cardiovascular risk prediction in secondary preventionNick S Nurmohamed, João P Belo Pereira, Renate M Hoogeveen, et al.
Pageof 2